生物活性 | |||
---|---|---|---|
描述 | Eliglustat tartrate, a specific inhibitor of glucosylceramide synthase, is under development as an oral substrate reduction therapy for Gaucher disease type 1 (GD1). |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.04mL 0.21mL 0.10mL |
5.21mL 1.04mL 0.52mL |
10.43mL 2.09mL 1.04mL |
参考文献 |
---|